GO:0009448 obsolete GABA metabolic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0009448 is an obsolete Gene Ontology biological_process term that formerly described the chemical reactions and pathways involving gamma-aminobutyric acid (GABA, 4-aminobutyrate), an amino acid neurotransmitter.
• The term has been retired from the active GO ontology and its content is now distributed across successor terms covering GABA biosynthesis, catabolism, transport, and signaling.
• GABA metabolism is clinically important because disruptions in GABA homeostasis are linked to anxiety disorders, dystonia, and alcohol withdrawal syndrome [1,2,4].
• Key enzymes historically associated with this term include GAD1, GAD2, ABAT, and SSADH, which control GABA synthesis and degradation [1,4].
• Pyridoxal-5'-phosphate (PLP, vitamin B6) is an essential cofactor for GAD and ABAT, linking GABA metabolism to nutritional and toxicological research.
• Modern studies of GABA metabolism use CRISPR knockout, point-mutation, knock-in, and overexpression models combined with metabolomics and transcriptomics [3,5].
Description
GO:0009448, obsolete GABA metabolic process, was a Gene Ontology biological_process term defined as the chemical reactions and pathways involving gamma-aminobutyric acid (GABA, 4-aminobutyrate), an amino acid that acts as a neurotransmitter in some organisms. Although the term is now obsolete, the biology it described remains central to neurobiology, metabolism, and pharmacology. GABA is the principal inhibitory neurotransmitter in the mammalian central nervous system, and its metabolic pathways are tightly coupled to the tricarboxylic acid cycle and to vitamin B6-dependent enzymes [1,4]. Researchers studying neurological and psychiatric disorders continue to interrogate GABA metabolism because altered GABA levels are associated with conditions such as anxiety disorders, dystonia, and alcohol withdrawal syndrome [1,2,4]. The retirement of GO:0009448 reflects ontology curation rather than a loss of biological relevance; the underlying reactions are now captured by more specific GO terms for GABA biosynthetic and catabolic processes. This article reviews the definition, mechanism, key genes, disease links, and experimental methods relevant to the obsolete term, providing a publication-ready resource for researchers who encounter GO:0009448 in legacy annotations and literature [1,3,5].
obsolete GABA metabolic process At A Glance
| GO ID | GO:0009448 |
|---|---|
| GO term | obsolete GABA metabolic process |
| Ontology | biological_process |
| Synonym | 4-aminobutanoate metabolic process; 4-aminobutanoate metabolism; 4-aminobutyrate metabolic process; 4-aminobutyrate metabolism; GABA metabolism; gamma-aminobutyric acid metabolic process; gamma-aminobutyric acid metabolism |
| Major function | Chemical reactions and pathways involving gamma-aminobutyric acid (GABA, 4-aminobutyrate), an amino acid neurotransmitter |
| Status | Obsolete; replaced by more specific GO terms for GABA biosynthesis, catabolism, transport, and signaling |
| Key enzymes | GAD1, GAD2, ABAT, SSADH, and related PLP-dependent enzymes [1,4] |
| Cofactor | Pyridoxal-5'-phosphate (PLP, vitamin B6) for GAD and ABAT |
| Clinical relevance | Anxiety disorders, dystonia, alcohol withdrawal syndrome, and other neurological conditions [1,2,4] |
What Is GO:0009448?
GO:0009448 (obsolete GABA metabolic process) was defined in QuickGO as the chemical reactions and pathways involving gamma-aminobutyric acid (GABA, 4-aminobutyrate), an amino acid which acts as a neurotransmitter in some organisms. The term carried synonyms including 4-aminobutanoate metabolic process, 4-aminobutyrate metabolism, GABA metabolism, and gamma-aminobutyric acid metabolic process. Because the term is obsolete, it should no longer be used for new annotations; instead, researchers should map its content to successor terms that separately describe GABA biosynthesis, GABA catabolism, GABA transport, and GABA signaling. In practice, the obsolete term encompassed the enzymatic conversion of glutamate to GABA by glutamate decarboxylase, the catabolism of GABA via GABA transaminase and succinic semialdehyde dehydrogenase, and the associated cofactor and transport processes [1,4].
Why Is obsolete GABA metabolic process Important in Cell Biology?
Although GO:0009448 is obsolete, the biology it represented remains highly important because GABA is the main inhibitory neurotransmitter in the brain and its metabolic balance determines neuronal excitability, muscle tone, and behavioral state. Disruptions in GABA metabolism have been implicated in anxiety disorders, dystonia, and alcohol withdrawal syndrome, and vitamin B6-dependent enzymes such as GAD and ABAT are therapeutic targets [1,2,4]. For researchers, understanding the obsolete term helps interpret legacy GO annotations and design modern experiments that map to successor terms, ensuring that transcriptomic, proteomic, and CRISPR-based studies are correctly annotated [1,3,5].
• GABA is the principal inhibitory neurotransmitter, and its metabolic pathways control neuronal excitability.
• Altered GABA metabolism is associated with anxiety disorders and other psychiatric conditions.
• Dystonia, including nonprimary dystonias, has been linked to disturbances in GABAergic transmission and metabolism.
• Alcohol withdrawal syndrome involves GABAergic dysregulation, and pyridoxine/PLP repletion has been hypothesized to improve outcomes.
• GABA metabolism intersects with the tricarboxylic acid cycle through the GABA shunt, influencing energy metabolism.
• PLP-dependent enzymes GAD and ABAT are targets for pharmacological and nutritional interventions.
• Legacy GO annotations using GO:0009448 require mapping to successor terms for accurate functional enrichment.
• CRISPR-based models of GABA metabolic genes enable causal testing of disease hypotheses [3,5].
• Metabolomic and transcriptomic profiling of GABA pathway genes supports biomarker discovery [3,5].
• Understanding GABA metabolism aids development of drugs for epilepsy, anxiety, and movement disorders [1,2,4].
What Happens During obsolete GABA metabolic process?
GABA biosynthesis from glutamate
In simple terms: The brain makes GABA by removing a carboxyl group from glutamate.
The obsolete term GO:0009448 encompassed the biosynthesis of GABA from glutamate, catalyzed by glutamate decarboxylase (GAD) enzymes GAD1 and GAD2. These enzymes require pyridoxal-5'-phosphate (PLP, vitamin B6) as a cofactor, and their activity determines the availability of GABA for synaptic release. In legacy annotations, this step was considered part of GABA metabolism, although current GO terms separate biosynthesis from catabolism.
GABA catabolism via the GABA shunt
In simple terms: GABA is broken down and fed back into cellular energy pathways.
GABA catabolism begins with GABA transaminase (ABAT), which converts GABA and alpha-ketoglutarate to succinic semialdehyde and glutamate. Succinic semialdehyde is then oxidized by succinic semialdehyde dehydrogenase (SSADH) to succinate, which enters the tricarboxylic acid cycle. This pathway, known as the GABA shunt, was included in the obsolete term and remains a key metabolic route linking neurotransmitter turnover to energy metabolism [1,4].
Cofactor and vitamin B6 dependence
In simple terms: Vitamin B6 is required for the enzymes that make and break down GABA.
Both GAD and ABAT are PLP-dependent enzymes, making vitamin B6 status a critical determinant of GABA metabolic flux. Pyridoxine/pyridoxal-5'-phosphate repletion has been hypothesized to improve outcomes in alcohol withdrawal syndrome by supporting GABA metabolism. This cofactor dependence was an implicit part of the obsolete term's biology and is now captured in annotations for the individual enzymes [1,4].
Transport and compartmentalization
In simple terms: GABA must be moved into and out of cells and vesicles to function.
Although GO:0009448 focused on chemical reactions, the obsolete term was often used in annotations that also involved GABA transport and vesicular packaging. GABA is synthesized in the cytoplasm, packaged into synaptic vesicles, and released into the synaptic cleft, where it acts on GABA receptors. Reuptake and degradation terminate its action, and these processes are now described by separate GO terms for transport and catabolism.
Regulation of GABA metabolic flux
In simple terms: The amount of GABA made and destroyed is adjusted to meet neuronal demand.
GABA metabolic flux is regulated by enzyme expression, cofactor availability, and feedback from neuronal activity [1,4]. GAD activity can be modulated by PLP availability and by post-translational mechanisms, while ABAT and SSADH activities influence the rate of GABA breakdown [1,4]. In legacy literature, these regulatory features were often discussed under the umbrella of GABA metabolism, corresponding to GO:0009448.
Key Genes Involved in GO:0009448 obsolete GABA metabolic process
The following genes and proteins are historically associated with the biology described by obsolete GABA metabolic process (GO:0009448) and its successor terms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GAD1 | Glutamate decarboxylase 1; synthesizes GABA from glutamate | Target for studies of GABAergic dysfunction in dystonia and anxiety [1,2] |
| GAD2 | Glutamate decarboxylase 2; synthesizes GABA from glutamate | Isoform-specific roles in neurotransmitter pools and disease models |
| ABAT | 4-aminobutyrate aminotransferase; catabolizes GABA | Key enzyme in GABA shunt; linked to neurological disorders [1,4] |
| SSADH | Succinic semialdehyde dehydrogenase; oxidizes succinic semialdehyde | Deficiency causes GABA-related metabolic disease |
| SLC6A1 | GABA transporter; regulates extracellular GABA levels | Associated with epilepsy and neurodevelopmental disorders |
| SLC6A11 | GABA transporter; regulates extracellular GABA levels | Target for studies of GABA reuptake |
| GABRA1 | GABA-A receptor subunit; mediates inhibitory signaling | Receptor subunit linked to epilepsy and anxiety [1,2] |
| GABRB2 | GABA-A receptor subunit; mediates inhibitory signaling | Genetic variants associated with psychiatric phenotypes |
| GABRG2 | GABA-A receptor subunit; mediates inhibitory signaling | Mutations linked to epilepsy syndromes |
| GABBR1 | GABA-B receptor subunit; mediates slow inhibitory signaling | Target for spasticity and pain research |
| GABBR2 | GABA-B receptor subunit; mediates slow inhibitory signaling | Involved in neurological and psychiatric models |
| ALDH5A1 | Aldehyde dehydrogenase 5 family member A1; SSADH activity | Deficiency causes succinic semialdehyde dehydrogenase deficiency |
| MAOB | Monoamine oxidase B; contributes to GABA-related amine metabolism | Indirect role in neurotransmitter metabolism |
| PLP-related enzymes | Pyridoxal-5'-phosphate-dependent enzymes | Cofactor supply affects GABA synthesis and catabolism |
| SLC32A1 | Vesicular GABA transporter; packages GABA into vesicles | Essential for inhibitory neurotransmission |
| GAD67 | Alternative name for GAD1; major GABA-synthesizing enzyme | Widely studied in neurodevelopmental disorders |
| GAD65 | Alternative name for GAD2; synaptic GABA synthesis | Autoantigen in stiff-person syndrome and diabetes |
How Is obsolete GABA metabolic process Regulated?
GABA metabolic flux is regulated at multiple levels, including transcriptional control of GAD1, GAD2, ABAT, and SSADH, availability of the cofactor pyridoxal-5'-phosphate, and feedback from neuronal activity [1,4]. Pyridoxine/pyridoxal-5'-phosphate repletion has been proposed to modulate GABA metabolism in alcohol withdrawal syndrome, highlighting nutritional regulation. Although the obsolete term GO:0009448 did not specify regulatory mechanisms, legacy annotations often included these contextual factors.
obsolete GABA metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GAD1 | Dystonia and GABAergic dysfunction | CRISPR knockout in neuronal cell lines |
| GAD2 | Anxiety and neurotransmitter imbalance | Point-mutation knock-in in mice |
| ABAT | GABA shunt disorders and neurological phenotypes | Knockout zebrafish or cell models |
| SSADH (ALDH5A1) | Succinic semialdehyde dehydrogenase deficiency | Patient-derived iPSC knock-in |
| SLC6A1 | Epilepsy and neurodevelopmental disorders | Overexpression and knockout in neurons |
GABA metabolism in dystonia
Nonprimary dystonias have been associated with disturbances in GABAergic transmission and metabolism, and genes such as GAD1 and GAD2 are candidates for further study. The obsolete term GO:0009448 was historically used to annotate genes involved in these pathways, and modern research maps them to successor terms.
GABA metabolism and anxiety disorders
Anxiety disorders involve dysregulation of inhibitory neurotransmission, and GABA metabolism is a longstanding focus of pharmacological and genetic research. Although the obsolete term is no longer active, its biological content remains relevant to studies of GABAergic dysfunction in anxiety [1,2].
GABA metabolism in alcohol withdrawal syndrome
Alcohol withdrawal syndrome is characterized by GABAergic dysregulation, and pyridoxine/pyridoxal-5'-phosphate repletion has been hypothesized to improve outcomes by supporting GABA metabolism. This hypothesis links nutritional cofactors to the enzymatic steps formerly covered by GO:0009448.
GABA metabolism and metabolic engineering
GABA metabolic pathways are also relevant in biotechnology, where synthetic pathways for related dicarboxylic acids such as glutarate have been engineered in Corynebacterium glutamicum. Such work demonstrates that GABA-related metabolic enzymes can be repurposed for industrial production.
From obsolete GABA metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GAD1 reduce GABA synthesis? | CRISPR knockout in GABAergic neurons |
| Does a point mutation in ABAT alter enzyme kinetics? | Point-mutation knock-in cell lines |
| Can wild-type SSADH rescue metabolic defects? | Knock-in of wild-type ALDH5A1 |
| Where is GAD2 expressed in vivo? | Tagged knock-in reporter mice |
| Does overexpression of SLC6A1 change GABA uptake? | Overexpression in neuronal cultures |
| Can engineered pathways produce glutarate? | Metabolic engineering in C. glutamicum |
How to Study the obsolete GABA metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Expression of GABA pathway genes | Mapping legacy annotations to successor terms |
| Metabolomics | GABA and intermediate concentrations | Assessing metabolic flux in cells and tissues |
| Enzyme activity assay | GAD and ABAT catalytic rates | Functional validation of variants [1,4] |
| CRISPR knockout | Loss-of-function effects on GABA metabolism | Causal gene testing |
| CRISPR point mutation | Effect of specific variants on enzyme function | Modeling patient mutations |
| Knock-in reporter | Localization and expression of GABA genes | In vivo studies of GABAergic neurons |
| Overexpression | Gain-of-function effects on GABA levels | Testing transporter or enzyme dosage |
| Bioinformatics enrichment | Overrepresentation of obsolete GO terms | Re-annotation of legacy datasets |
Transcriptomic profiling of GABA pathway genes
RNA-seq can quantify expression of GAD1, GAD2, ABAT, SSADH, and GABA receptor subunits across conditions, helping map legacy GO:0009448 annotations to modern terms [1,3].
Metabolomic measurement of GABA and intermediates
Mass spectrometry-based metabolomics quantifies GABA, glutamate, succinate, and related metabolites, providing direct readouts of GABA metabolic flux [3,4].
Enzymatic assays for GAD and ABAT activity
In vitro assays using recombinant GAD or ABAT measure catalytic activity and cofactor dependence, supporting functional interpretation of variants [1,4].
CRISPR screening for GABA metabolic regulators
Pooled CRISPR screens can identify genes that modify GABA levels or GABAergic phenotypes, linking candidate genes to the obsolete term's biology [3,5].
How CRISPR Can Be Used to Study GO:0009448 obsolete GABA metabolic process
Knockout
CRISPR knockout of GAD1, GAD2, ABAT, or SSADH can abolish specific GABA metabolic steps, enabling causal tests of their roles in neuronal function and disease [1,3].
Point Mutation
Point-mutation knock-in models can replicate patient variants in GABA metabolic enzymes, allowing assessment of catalytic activity and cofactor binding [1,4].
Knock-in
Knock-in of tagged or reporter alleles at GABA pathway loci enables visualization of enzyme localization and cell-type-specific expression in vivo.
Overexpression
Overexpression of GABA transporters or enzymes can test gain-of-function effects on GABA levels and inhibitory neurotransmission.
How EDITGENE Supports obsolete GABA metabolic process Research
Researchers studying obsolete GABA metabolic process-related genes often need to determine whether a candidate gene is causally involved in GABA synthesis, catabolism, or signaling. EDITGENE provides CRISPR-based cell models and screening services to support such investigations, from knockout validation to point-mutation modeling and overexpression studies [1,3,5].
Contact EDITGENE today to design your custom CRISPR model for obsolete GABA metabolic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| ABAT Knockout HEK293 Cell Line | EDJ-KQ2710 | Human | 18 | Details Get a Quote |
| ABAT Knockout HCT 116 Cell Line | EDJ-KQ23556 | Human | 18 | Details Get a Quote |
| ABAT Knockout HeLa Cell Line | EDJ-KQ52532 | Human | 18 | Details Get a Quote |
| ABAT Knockout A-549 Cell Line | EDJ-KQ61013 | Human | 18 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records
Frequently Asked Questions About obsolete GABA metabolic process
What is GO:0009448 obsolete GABA metabolic process?
GO:0009448 was a Gene Ontology biological_process term describing the chemical reactions and pathways involving gamma-aminobutyric acid (GABA, 4-aminobutyrate), an amino acid neurotransmitter; it is now obsolete.
Why is GO:0009448 obsolete?
The term was retired because its content is now covered by more specific GO terms for GABA biosynthesis, catabolism, transport, and signaling.
What genes are involved in GABA metabolism?
Key genes include GAD1, GAD2, ABAT, SSADH (ALDH5A1), SLC6A1, SLC6A11, and GABA receptor subunits such as GABRA1 [1,4].
What diseases are linked to GABA metabolic process?
GABA metabolism has been linked to dystonia, anxiety disorders, alcohol withdrawal syndrome, and succinic semialdehyde dehydrogenase deficiency [1,2,4].
What is the GABA shunt?
The GABA shunt is a metabolic pathway that converts GABA to succinate via ABAT and SSADH, feeding into the tricarboxylic acid cycle.
How can I study GABA metabolism with CRISPR?
CRISPR knockout, point-mutation knock-in, and overexpression models can be used to test the function of GABA pathway genes in cells and neurons [1,3].
What cofactor is required for GABA synthesis?
Pyridoxal-5'-phosphate (PLP, vitamin B6) is required for GAD and ABAT activity.
Is GABA metabolism related to alcohol withdrawal?
Yes, GABAergic dysregulation is involved in alcohol withdrawal syndrome, and pyridoxine/PLP repletion has been hypothesized to improve outcomes.
What are successor terms for GO:0009448?
Successor terms include GO terms for GABA biosynthetic process, GABA catabolic process, GABA transport, and GABA signaling.
Can GABA metabolic pathways be engineered for biotechnology?
Yes, synthetic pathways related to GABA metabolism have been engineered in Corynebacterium glutamicum for production of dicarboxylic acids such as glutarate.
Conclusion
GO:0009448 obsolete GABA metabolic process remains a useful historical annotation for understanding GABA biology, even though it has been replaced by more specific GO terms. The pathways it described, including GABA synthesis by GAD and catabolism via the GABA shunt, are central to neuronal inhibition and are implicated in dystonia, anxiety, and alcohol withdrawal syndrome [1,2,4]. Modern CRISPR-based models and metabolomic methods allow researchers to dissect these pathways with causal precision, and EDITGENE provides the tools to generate such models [3,5].
References
- 1. Dressler D. 2011. Nonprimary dystonias.. Handb Clin Neurol 100:513-38 PMID: 21496605
- 2. Friedman D et al.. 1983. Anxiety disorders.. J Fam Pract 16(1):145-52 PMID: 6129279
- 3. Pérez-García F et al.. 2018. Efficient Production of the Dicarboxylic Acid Glutarate by Corynebacterium glutamicum via a Novel Synthetic Pathway.. Front Microbiol 9:2589 PMID: 30425699
- 4. Weintraub SJ. 2026. Pyridoxine/pyridoxal-5'-phosphate repletion to improve outcomes of alcohol withdrawal syndrome and promote long-term abstinence: a hypothesis.. Clin Toxicol (Phila) PMID: 42480097
- 5. Vedani A et al.. 2003. Internet laboratory for predicting harmful effects triggered by drugs and chemicals--a progress report.. ALTEX 20(2):85-91 PMID: 12764545
